Search research articles
Contact Us
Filters
Showing results (1-10 of 433) with videos related to
Page
of 44
Sort By:
World Journal of Gastroenterology
|
June 27, 2014
When to stop nucleos(t)ide analogues treatment for chronic hepatitis B? Durability of antiviral response
Wonseok Kang, Jun Yong Park
Biomed Research International
|
January 24, 2014
Clinical significance of AFP and PIVKA-II responses for monitoring treatment outcomes and predicting prognosis in patients with hepatocellular carcinoma
Hana Park, Jun Yong Park
Cancer Cell International
|
January 6, 2017
Regulation of the hypoxic tumor environment in hepatocellular carcinoma using RNA interference
Sung Hoon Choi, Jun Yong Park
Expert Opinion on Pharmacotherapy
|
August 16, 2021
Besifovir dipivoxil maleate: a novel antiviral agent with low toxicity and high genetic barriers for chronic hepatitis B
Jeong Eun Song, Jun Yong Park
International Journal of Hepatology
|
April 23, 2013
Prevention and management of variceal hemorrhage
Dong Hyun Kim, Jun Yong Park
The Korean Journal of Hepatology
|
September 26, 2006
[Primary biliary cirrhosis]
Chae Yoon Chon, Jun Yong Park
Cancer Cell International
|
July 19, 2017
Erratum to: Regulation of the hypoxic tumor environment in hepatocellular carcinoma using RNA interference
Sung Hoon Choi, Jun Yong Park
Journal of Liver Cancer
|
June 29, 2023
Nivolumab for Advanced Hepatocellular Carcinoma with Multiple Lung Metastases after Sorafenib Failure
Jaewoong Kim, Jin Won Chang, Jun Yong Park
ACS Biomaterials Science & Engineering
|
January 15, 2021
Antiadhesion Function between a Biological Surface and a Metallic Device Interface at High Temperature by Wettability Control
Jun-Yong Park, Mizuki Tenjimbayashi, Jun Muto, et al.
Immune Network
|
March 12, 2020
Current Status and Future Direction of Immunotherapy in Hepatocellular Carcinoma: What Do the Data Suggest?
Hye Won Lee, Kyung Joo Cho, Jun Yong Park
Page
of 44
Search research articles
Search
Showing results (1-10 of 433) with videos related to
Sort By:
Page
of 44
World Journal of Gastroenterology
|
June 27, 2014
When to stop nucleos(t)ide analogues treatment for chronic hepatitis B? Durability of antiviral response
Wonseok Kang, Jun Yong Park
Biomed Research International
|
January 24, 2014
Clinical significance of AFP and PIVKA-II responses for monitoring treatment outcomes and predicting prognosis in patients with hepatocellular carcinoma
Hana Park, Jun Yong Park
Cancer Cell International
|
January 6, 2017
Regulation of the hypoxic tumor environment in hepatocellular carcinoma using RNA interference
Sung Hoon Choi, Jun Yong Park
Expert Opinion on Pharmacotherapy
|
August 16, 2021
Besifovir dipivoxil maleate: a novel antiviral agent with low toxicity and high genetic barriers for chronic hepatitis B
Jeong Eun Song, Jun Yong Park
International Journal of Hepatology
|
April 23, 2013
Prevention and management of variceal hemorrhage
Dong Hyun Kim, Jun Yong Park
The Korean Journal of Hepatology
|
September 26, 2006
[Primary biliary cirrhosis]
Chae Yoon Chon, Jun Yong Park
Cancer Cell International
|
July 19, 2017
Erratum to: Regulation of the hypoxic tumor environment in hepatocellular carcinoma using RNA interference
Sung Hoon Choi, Jun Yong Park
Journal of Liver Cancer
|
June 29, 2023
Nivolumab for Advanced Hepatocellular Carcinoma with Multiple Lung Metastases after Sorafenib Failure
Jaewoong Kim, Jin Won Chang, Jun Yong Park
ACS Biomaterials Science & Engineering
|
January 15, 2021
Antiadhesion Function between a Biological Surface and a Metallic Device Interface at High Temperature by Wettability Control
Jun-Yong Park, Mizuki Tenjimbayashi, Jun Muto, et al.
Immune Network
|
March 12, 2020
Current Status and Future Direction of Immunotherapy in Hepatocellular Carcinoma: What Do the Data Suggest?
Hye Won Lee, Kyung Joo Cho, Jun Yong Park
Page
of 44